BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16698893)

  • 1. NMR characterization of an S-linked glucuronide metabolite of the potent, novel, nonsteroidal progesterone agonist tanaproget.
    Keating KA; McConnell O; Zhang Y; Shen L; Demaio W; Mallis L; Elmarakby S; Chandrasekaran A
    Drug Metab Dispos; 2006 Aug; 34(8):1283-7. PubMed ID: 16698893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
    Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
    Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.
    Fensome A; Bender R; Chopra R; Cohen J; Collins MA; Hudak V; Malakian K; Lockhead S; Olland A; Svenson K; Terefenko EA; Unwalla RJ; Wilhelm JM; Wolfrom S; Zhu Y; Zhang Z; Zhang P; Winneker RC; Wrobel J
    J Med Chem; 2005 Aug; 48(16):5092-5. PubMed ID: 16078826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of two chloramphenicol glucuronides from the in vitro glucuronidation of chloramphenicol in human liver microsomes.
    Chen M; Howe D; Leduc B; Kerr S; Williams DA
    Xenobiotica; 2007 Sep; 37(9):954-71. PubMed ID: 17896323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization.
    Li C; Chauret N; Trimble LA; Nicoll-Griffith DA; Silva JM; MacDonald D; Perrier H; Yergey JA; Parton T; Alexander RP; Warrellow GJ
    Drug Metab Dispos; 2001 Mar; 29(3):232-41. PubMed ID: 11181489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a phase I metabolite.
    Schwartz MS; Desai RB; Bi S; Miller AR; Matuszewski BK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):116-24. PubMed ID: 16716772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which hydroxy? Evidence for species differences in the regioselectivity of glucuronidation in rat, dog, and human in vitro systems and dog in vivo.
    Martin IJ; Lewis RJ; Bernstein MA; Beattie IG; Martin CA; Riley RJ; Springthorpe B
    Drug Metab Dispos; 2006 Sep; 34(9):1502-7. PubMed ID: 16763016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and identification of the quaternary ammonium-linked glucuronide of 1-phenylimidazole in human liver microsomes and investigation of the human UDP-glucuronosyltransferases involved.
    Vashishtha SC; Hawes EM; McKay G; McCann DJ
    Drug Metab Dispos; 2000 Sep; 28(9):1009-13. PubMed ID: 10950841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation and identification of the human N+-glucuronide metabolite of cediranib.
    Lenz EM; Spear M; Drake C; Pollard CR; Ward M; Schulz-Utermoehl T; Harrison M
    J Pharm Biomed Anal; 2010 Nov; 53(3):526-36. PubMed ID: 20409669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of 2,3,3,3-tetrafluoropropene (HFO-1234yf).
    Schuster P; Bertermann R; Snow TA; Han X; Rusch GM; Jepson GW; Dekant W
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):323-32. PubMed ID: 18817801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-assisted synthesis and characterization of glucuronide conjugates of neuroactive steroids.
    Jäntti SE; Kiriazis A; Reinilä RR; Kostiainen RK; Ketola RA
    Steroids; 2007 Mar; 72(3):287-96. PubMed ID: 17250861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of the quaternary ammonium-linked glucuronide of nicotine in human liver microsomes: identification and stereoselectivity in the kinetics.
    Ghosheh O; Vashishtha SC; Hawes EM
    Drug Metab Dispos; 2001 Dec; 29(12):1525-8. PubMed ID: 11717169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo phase II metabolism of combretastatin A-4: evidence for the formation of a sulphate conjugate metabolite.
    Aprile S; Del Grosso E; Grosa G
    Xenobiotica; 2009 Feb; 39(2):148-61. PubMed ID: 19255941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characterization of novel adenine dinucleotide phosphate conjugates of imatinib in incubations with rat and human liver microsomes.
    Ma S; Subramanian R; Xu Y; Schrag M; Shou M
    Drug Metab Dispos; 2008 Dec; 36(12):2414-8. PubMed ID: 18799804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, structure characterization, and enzyme screening of clenbuterol glucuronides.
    Alonen A; Gartman M; Aitio O; Finel M; Yli-Kauhaluoma J; Kostiainen R
    Eur J Pharm Sci; 2009 Jul; 37(5):581-7. PubMed ID: 19447177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy.
    Walker GS; Atherton J; Bauman J; Kohl C; Lam W; Reily M; Lou Z; Mutlib A
    Chem Res Toxicol; 2007 Jun; 20(6):876-86. PubMed ID: 17536843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-assisted synthesis and structural characterization of pure benzodiazepine glucuronide epimers.
    Pallmann T; Jonas U; Wagner M; Thevis M; Kaeferstein H; Rothschild MA; Bender K
    Eur J Pharm Sci; 2010 Feb; 39(4):233-40. PubMed ID: 20036738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a hydroxylamine glucuronide metabolite of an oral hypoglycemic agent.
    Miller RR; Doss GA; Stearns RA
    Drug Metab Dispos; 2004 Feb; 32(2):178-85. PubMed ID: 14744939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tertiary N-glucuronides of clozapine and its metabolite desmethylclozapine in patient urine.
    Breyer-Pfaff U; Wachsmuth H
    Drug Metab Dispos; 2001 Oct; 29(10):1343-8. PubMed ID: 11560879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.